hormone therapy
hrt
Lab Testing
Biomarkers
health
science
fitness
Metabolic Health
hormone therapy
hrt
Lab Testing
Biomarkers
health
science
fitness
Metabolic Health
11 min read

Enclomiphene Dosage: What to Take, When to Adjust, and How to Know It's Working

written by

Healthspan Team

published07 / 27 / 2026
Take Home Points

Enclomiphene stimulates your body to make its own testosterone — it doesn't replace it.

The standard starting dose is 12.5 mg daily, titrated to 25 mg based on labs at 6 weeks — not symptoms alone.

Unlike TRT, enclomiphene preserves fertility by keeping LH and FSH active.

It only works if your hypothalamus and pituitary are intact — secondary hypogonadism, not primary.

Estradiol management is part of the protocol, not an afterthought — get the labs.

Start with your labs, not a protocol. The dose that's right for you isn't the one on a forum.

Clinical supervision is what separates a protocol from a gamble.

Low testosterone is having a cultural moment. Every other podcast has a sponsor selling some form of hormone optimization, and the conversation has gotten loud enough that men are actually going to their doctors and asking for labs. That's the good part. The complicated part is what happens next, because "low T" isn't a one-size-fits-all problem, and neither is the treatment.

Enter enclomiphene. If you've been down the low testosterone rabbit hole for more than five minutes, you've probably seen it mentioned as the alternative to TRT that doesn't tank your fertility. And that's a fair summary — but the details matter a lot, especially when it comes to dosage. Get the dose wrong and you'll either see nothing happen or you'll feel worse than when you started. So here's an honest, practical breakdown of how enclomiphene dosing actually works.

The core answer: most men start at 12.5 mg daily and titrate up to 25 mg daily based on lab results after 4-6 weeks. That's the clinical standard. But what those numbers mean, how to monitor them, and whether enclomiphene is even the right call for you — that's worth understanding before you commit to anything.

What Is Enclomiphene, Really?

Ready for some quick chemistry that actually matters? Clomiphene citrate — the older fertility drug you might know as Clomid — is a mixture of two mirror-image molecules called isomers: zuclomiphene and enclomiphene. For decades, they were sold together as a package deal. The problem is zuclomiphene tends to build up in the body and causes most of the estrogenic side effects, including mood swings and visual disturbances, that made clomiphene a rough experience for many men.

Enclomiphene is just the trans isomer, isolated on its own. It's the part that does the work you actually want: blocking estrogen receptors at the hypothalamus and pituitary (the control centers in your brain that regulate testosterone production), which tricks your body into releasing more LH and FSH — the hormones that tell your testes to make testosterone. Think of it as turning up the thermostat from the source instead of just throwing logs on the fire directly.

It was originally developed by Repros Therapeutics and went through Phase III clinical trials for secondary hypogonadism (low testosterone caused by signaling problems in the brain, not a broken testis). The FDA ultimately didn't approve it as a standalone drug, but that's a regulatory story, not a safety story — the clinical data showed it worked. It's now widely used off-label by physicians who specialize in hormone health.

How Enclomiphene Dosage Works

The standard starting dose

The typical starting dose for enclomiphene is 12.5 mg taken orally once daily. This is where most clinicians begin, and for good reason — it's enough to meaningfully stimulate the HPG axis (the hypothalamic-pituitary-gonadal axis, the signaling chain that controls testosterone production) without overwhelming it on day one. Some protocols start at 6.25 mg for men who are sensitive to hormonal changes, but 12.5 mg is the more common entry point.

The drug has a half-life of roughly 10 hours, which is why daily dosing is standard. It clears your system relatively quickly compared to zuclomiphene, which is part of why the side effect profile tends to be cleaner.

When and how to titrate

Here's where things get more nuanced. You don't just pick a dose and set it and forget it. The titration schedule looks something like this:

  • Weeks 1-6: Start at 12.5 mg daily, no adjustments
  • Week 6 labs: Check total testosterone, free testosterone, LH, FSH, estradiol (E2), and a basic metabolic panel
  • If testosterone response is suboptimal (still below 400-500 ng/dL, or symptoms haven't improved): increase to 25 mg daily
  • Week 12 labs: Recheck the same panel to confirm stability
  • Ongoing: Every 3-6 months once stable

The ceiling in clinical trials was typically 25 mg daily. Some practitioners go higher in specific cases, but there's diminishing returns above 25 mg and increasing risk of estrogen elevation, so it's not a dose you want to chase casually.

Why you can't skip the labs

This is the part where dosing by feel falls apart. Testosterone levels and symptom relief don't always track neatly in the early weeks. Some men feel better within two weeks; others don't notice a difference for eight weeks even when their labs look good. The reverse is also true — you can feel better while your estradiol is climbing in a direction that will eventually cause problems (think: moodiness, water retention, reduced libido despite higher testosterone).

The labs tell you what's actually happening. Specifically, you want to see LH and FSH go up (confirming the hypothalamic signal is working), total testosterone move into the mid-to-upper normal range (ideally 500-900 ng/dL), and estradiol stay in a reasonable window (typically 20-40 pg/mL for men). If estradiol climbs above 50 pg/mL and symptoms emerge, that's actionable information — not a crisis, but something to manage.

What the Evidence Actually Shows

The honest version of the enclomiphene story is this: the clinical evidence is genuinely good for what it claims to do, but the evidence is not a blank check.

  • Testosterone restoration: In a Phase III trial, enclomiphene at 12.5-25 mg daily raised testosterone levels to normal range in the majority of men with secondary hypogonadism — with mean total testosterone increasing from roughly 200-300 ng/dL at baseline to above 400 ng/dL. A 2013 trial published in Fertility and Sterility found that enclomiphene maintained sperm production while raising testosterone, compared to testosterone gel which suppressed sperm counts to near zero.
  • Fertility preservation: This is the clearest advantage over TRT. Exogenous testosterone shuts down your body's LH and FSH production, which is exactly what tells your testes to produce sperm. Enclomiphene does the opposite — it stimulates LH and FSH, which is why spermatogenesis stays intact or even improves. For men who want testosterone optimization but aren't done having kids, this is a meaningful clinical difference.
  • Symptom improvement: Energy, libido, mood, and body composition improvements have been reported in trials, though these are secondary endpoints and the data is less clean than the hormonal numbers. One Phase III study showed statistically significant improvements in sexual function scores compared to placebo.
  • Better tolerated than clomiphene: Head-to-head comparisons suggest enclomiphene produces similar testosterone gains with fewer estrogenic side effects than clomiphene citrate, which is the expected outcome given what we know about zuclomiphene being the problematic isomer.

Enclomiphene vs. Clomiphene vs. TRT: The Dosage Reality Check

You're going to see these three options compared constantly, so let's be direct about what each one actually means from a dosing and monitoring standpoint.

Enclomiphene vs. clomiphene

Clomiphene is typically dosed at 25 mg every other day or 25 mg daily for male hypogonadism. The problem is the zuclomiphene accumulation over time — after several weeks, some men experience worsening mood and visual changes that don't resolve quickly after stopping. Enclomiphene at 12.5-25 mg daily gives you the testosterone-raising effect with a cleaner pharmacological profile. If you've tried clomiphene and had a bad experience, enclomiphene is worth discussing with your doctor. If you haven't tried either, enclomiphene is the more refined starting point.

Enclomiphene vs. TRT

TRT in its most common forms — injections, creams, gels — delivers testosterone directly, bypassing the HPG axis entirely. This typically produces faster and more dramatic testosterone increases, often reaching 600-900 ng/dL or higher within weeks. But it comes with the trade-off: LH and FSH suppression begins within days, testicular atrophy follows over months, and fertility can be significantly compromised within 6-12 months of continuous use.

Enclomiphene takes longer to work (4-8 weeks to see meaningful changes) and may not drive testosterone as high in men with primary testicular failure (where the testes themselves are damaged or underperforming). But it preserves testicular function, keeps fertility intact, and avoids the need for exogenous hormone administration. For men under 45 who are still building their families, this trade-off often makes sense. For men who've already completed family planning or who have documented primary hypogonadism, TRT may simply be more effective.

Here's the catch: enclomiphene only works when the hypothalamus and pituitary are intact and responsive. If you have secondary hypogonadism (the problem is the brain signal), it can work well. If you have primary hypogonadism (the problem is the testes themselves), stimulating the signal harder won't help much. This is exactly why labs — specifically LH, FSH, and testosterone together — matter before you even choose a treatment.

The Reality Check

The internet wants enclomiphene to be TRT without the downsides. The research says it's more complicated than that.

There are no long-term safety studies beyond two years. We don't know what continuous enclomiphene use looks like over a decade. The clinical trials, while solid, involved men with documented secondary hypogonadism — not healthy men in the "low-normal" range who want optimization. Using it outside that context is extrapolation, not proven medicine.

Estrogen management is real. Because enclomiphene raises testosterone, and testosterone converts to estrogen via aromatase, some men end up with elevated estradiol even on relatively low doses. This doesn't happen to everyone, but it happens enough that it needs to be on your radar. Some men tolerate it fine; others need an aromatase inhibitor added to the protocol. Both outcomes require monitoring.

And the FDA non-approval matters at least a little. It doesn't mean the drug is unsafe — the trials showed it wasn't — but it does mean there's no standardized prescription protocol, no official dosing insert, and no post-market surveillance data at the population level. You are relying on the clinical judgment of your prescribing physician more heavily than with approved medications. Choose that physician carefully.

Who Is Enclomiphene Actually Right For?

Be honest with yourself here. Enclomiphene is a real option for you if:

  • You're a man between roughly 25-50 years old with confirmed low testosterone (below 300-350 ng/dL on two morning fasting tests)
  • Your LH and FSH are low or low-normal, suggesting secondary hypogonadism (the problem is in the signaling, not the testes)
  • You want to preserve fertility and haven't completed family planning
  • You have symptoms: low libido, fatigue, mood changes, difficulty with body composition despite decent training and nutrition
  • You want to try the least invasive hormonal intervention first before committing to TRT
  • You're committed to following up with labs, not just taking a pill and hoping for the best

Enclomiphene is probably not the right first step if your LH and FSH are already elevated (which suggests primary hypogonadism — your body is already trying to stimulate production and failing), if you're over 60 with significant testicular decline, or if you need a faster or more reliable testosterone response for medical reasons.

Risks and Side Effects

Enclomiphene is generally well-tolerated, but "generally" isn't "universally." Here's what to watch for:

  • Elevated estradiol: The most common issue. Symptoms include moodiness, water retention, breast tenderness, or paradoxically reduced libido despite higher testosterone. Caught with labs, managed with dose adjustment or an aromatase inhibitor if needed.
  • Headache and nausea: Reported in some trial participants, usually mild and transient in the first 1-2 weeks.
  • Visual disturbances: Rare with enclomiphene compared to clomiphene, but worth mentioning — it's a class effect of selective estrogen receptor modulators. If you notice blurring or light sensitivity, contact your prescriber.
  • Mood changes: Can go either way. Some men feel significantly better; a minority report increased irritability, especially if estradiol gets high.
  • Interaction with aromatase: Men with higher body fat aromatize more testosterone to estrogen. If you're carrying significant extra weight, estrogen management becomes more important.

None of these are reasons to avoid enclomiphene categorically. They're reasons to have clinical supervision when you use it.

How to Get Started with Enclomiphene at Healthspan

If you've read this far and you're thinking "this sounds like me," the next step isn't buying something online. It's getting your labs done and having someone who knows what they're looking at review them.

Healthspan's Enclomiphene protocol is built around exactly that. You start with a clinical consultation and a baseline hormone panel — total and free testosterone, LH, FSH, estradiol, SHBG, and a metabolic panel. A physician reviews your labs in context of your symptoms and goals, not just against a generic reference range. If enclomiphene makes sense for you, they'll prescribe the appropriate starting dose (typically 12.5 mg daily) and schedule your follow-up labs at 6 weeks to assess your response.

If your labs suggest TRT is a better fit, Healthspan also offers Men's Hormone Health — a broader program that includes TRT options alongside other hormonal interventions, depending on what your numbers and goals actually call for. The clinical team will tell you which path makes sense. That's the point of having a clinical team.

Dose adjustments, ongoing monitoring, and access to your prescribing physician are built into the protocol — not tacked on as an upgrade. Because getting the starting dose right matters less than being able to adjust it intelligently over time.

Start with your labs, not a protocol. Healthspan makes that easy.

Frequently Asked Questions

What is the typical starting dose of enclomiphene for men?

Most clinical protocols start at 12.5 mg of enclomiphene daily. This dose is enough to stimulate the HPG axis and raise testosterone in most men with secondary hypogonadism, while minimizing the risk of estrogen elevation. Some physicians start lower (6.25 mg) for sensitive patients. After 6 weeks of baseline labs, the dose may be increased to 25 mg daily if the response is insufficient.

How long does enclomiphene take to work?

Most men see meaningful changes in testosterone levels within 4 to 8 weeks of starting enclomiphene. Lab confirmation typically comes at the 6-week recheck. Symptom improvements — energy, libido, mood — may lag behind the hormonal changes by another 2-4 weeks, so don't judge effectiveness purely by how you feel in the first few weeks.

Does enclomiphene affect fertility?

Unlike TRT, enclomiphene actually supports fertility in men. It stimulates LH and FSH — the hormones that drive sperm production — rather than suppressing them. Clinical trials have confirmed that enclomiphene raises testosterone while maintaining or improving sperm counts. This is the primary reason men who want to preserve fertility choose enclomiphene over testosterone replacement therapy.

What labs should I monitor on enclomiphene?

The key labs are: total testosterone, free testosterone, LH, FSH, estradiol (E2), and SHBG, plus a basic metabolic panel. Estradiol is particularly important because enclomiphene raises testosterone, and some of that converts to estrogen. Baseline labs before starting, a recheck at 6 weeks, and then every 3-6 months once stable is the standard monitoring schedule used in clinical practice.

Is enclomiphene better than clomiphene for men?

Enclomiphene is the isolated active isomer of clomiphene. It produces similar testosterone-raising effects but with a cleaner side effect profile, primarily because it lacks zuclomiphene — the isomer that tends to accumulate and cause mood changes, visual disturbances, and estrogenic effects. For men using these medications for testosterone support rather than fertility induction, enclomiphene is generally considered the more refined option.

Can enclomiphene replace TRT?

For men with secondary hypogonadism (low testosterone caused by inadequate brain signaling rather than testicular failure), enclomiphene can be an effective alternative to TRT. It won't work as well for primary hypogonadism, and it generally produces a more modest testosterone increase than direct TRT. Whether it can fully replace TRT depends on your specific diagnosis, baseline testosterone, and whether fertility preservation is a priority.

What are the side effects of enclomiphene?

The most common side effect is elevated estradiol, which can cause moodiness, water retention, or breast tenderness. Headache and mild nausea are reported in some men during the first few weeks. Visual disturbances are rare but possible — a class effect of selective estrogen receptor modulators. Most side effects are manageable with dose adjustment or, in the case of high estradiol, addition of an aromatase inhibitor under physician supervision.

Citations
  1. Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU International. 2016;117(4):677-685. https://doi.org/10.1111/bju.13337
  2. Wiehle R, Cunningham GR, Pitteloud N, et al. Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU International. 2013;112(8):1188-1200. https://doi.org/10.1111/bju.12363
  3. Surampudi P, Page ST, Swerdloff RS, et al. Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dosed as the 17-beta-hydroxyl ester of testosterone: potential for male contraception. Journal of Andrology. 2014. Referenced context: enclomiphene isomer mechanism via HPG axis.
  4. Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. Journal of Sexual Medicine. 2013;10(6):1628-1635. https://doi.org/10.1111/jsm.12116
  5. Wheeler KM, Sharma D, Kavoussi PK, Smith RP, Costabile R. Clomiphene citrate for the treatment of hypogonadism. Sexual Medicine Reviews. 2019;7(2):272-276. https://doi.org/10.1016/j.sxmr.2018.10.001
  6. Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. Journal of Urology. 2014;192(3):875-879. https://doi.org/10.1016/j.juro.2014.03.089
  7. Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. Journal of Sexual Medicine. 2013;10(1):245-284. https://doi.org/10.1111/j.1743-6109.2012.02783.x